Share this article and save a life!
One AI model just beat every specialist radiologist AI.
And it might change how we think about medical AI forever.
Published March 5 in NEJM AI, MedVersa’s generalist model didn’t just compete with specialist systems, it matched or exceeded them across report generation, segmentation, detection, and visual question-answering tasks.
Here’s what makes this groundbreaking:
Specialist AI models are trained for one thing: chest X-rays, brain MRIs, mammograms. We’ve invested billions building separate tools for each imaging type.
But MedVersa proves a single model can do it all.
📊 The implications are massive:
• Lower implementation costs (one system vs. dozens)
• Simplified workflows for radiologists
• Faster deployment across health systems
• Better cross-modality pattern recognition
Think about what this means for community hospitals and FQHCs.
Instead of choosing between a lung nodule detector or a stroke identifier because of budget constraints, they get both. And more.
The model also boosted radiologist workflow efficiency in real-world testing. Not just accuracy, but speed.
But here’s the question nobody’s asking:
If one AI can master all of radiology, what happens to the dozens of specialized AI companies? Do we need 50 different chest X-ray algorithms when one generalist performs better?
This isn’t just about technology. It’s about access.
Smaller facilities that couldn’t afford multiple specialist AIs now have a path to world-class diagnostic support. One subscription, comprehensive coverage.
The specialist vs. generalist debate in medicine just got turned on its head.
Maybe the future isn’t hyperspecialization. Maybe it’s intelligent versatility.
♻️ Repost if generalist AI could democratize advanced diagnostics
👉 Follow me, Jonathan Govette, for daily, real-time updates on healthcare technology and business news. LinkedIn Profile: https://www.linkedin.com/in/jonathangovette/
Share this article and save a life!
Author:
CEO/Co-Founder @ Oatmeal Health | AI Lung Cancer Screening | Almost Became a Doctor | Engineer | Follow to Share What I’ve Learned Along the Way
I help patients get the care they need earlier, preventing late-stage cancer.
That’s been the throughline across three companies and almost 20 years in healthcare. At ReferralMD, we fixed broken referral networks so patients didn’t fall through the cracks. At Oatmeal Health, it’s lung cancer: building the diagnostic and screening infrastructure so the 85% of cases caught too late get caught early instead.
Today as CEO of Oatmeal Health, I lead a team embedding AI into radiology workflows to turn routine lung CT scans into reimbursable cancer risk assessments. We partner with FQHCs to reach underserved communities, and with health systems and payers to make early detection economically sustainable. Think HeartFlow or Cleerly, but for lungs.
Between companies, I advised at Techstars and Plug and Play, mentoring founders building in digital health. That experience shaped how I think about what separates companies that ship from companies that stall: distribution, reimbursement, and clinical trust, not just technology.
I’m a CancerX alumnus, a 3x healthcare founder, and someone who believes the biggest problems in cancer aren’t scientific. They’re operational.
We’re hiring mission-driven builders at Oatmeal Health. If you want to work on something that matters, reach out.
When I’m not working, I’m traveling, mentoring, and keeping up with one very energetic husky. 🐾
Substack – The Oatmeal Bite:
Millions of patients get less care because of who they are, where they live, or how they look. I’m fighting to change that. CEO @OatmealHealth, a startup built for the underserved. The Oatmeal Bite: intel for clinicians, investors, and advocates.
Jonathan Govette
CEO of Oatmeal Health
Substack:
https://oatmealhealthjonathangovette.substack.com/
